| Astute Metals NL (ASE) ORDINARY FULLY PAID |
Materials |
$15 |
Appointment of Chief Executive Officer
|
16 Aug 2024 9:17AM |
$0.035 |
$0.025 |
fallen by
28.57%
|
|
ASE - Price-sensitive ASX Announcement
Full Release
Key Points
- Appointment of Matthew Healy as CEO effective immediately.
- Mr. Healy's previous roles include Executive Director and General Manager – Exploration.
- Successful management of key projects in North America and Australia.
- No change to Mr. Healy's remuneration.
- Board and joint company secretaries fully support the appointment.
- Mr. Healy credited for the Red Mountain lithium discovery.
- Expectations for strong leadership to drive next phase of development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Connexion Mobility Ltd (CXZ) ORDINARY FULLY PAID |
Information Technology |
$21 |
Update - Notification of buy-back - CXZ
|
16 Aug 2024 9:16AM |
$0.028 |
$0.026 |
fallen by
7.14%
|
|
| Elixir Energy Limited (EXR) ORDINARY FULLY PAID |
Energy |
$41 |
Daydream-2 Operations Update
|
16 Aug 2024 9:16AM |
$0.110 |
$0.029 |
fallen by
73.64%
|
|
EXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Lorelle Sandstone flows gas at stabilized flow rates of 2.1 and 2.5 MMSCFPD
- Flow rate of Lorelle zone alone approaching the modeled economic hurdle
- Five stage stimulation program now underway
- Lorelle Sandstone flow tested at multiple rates with a maximum rate of 3.5 MMSCFPD
- Stimulation fluid accumulation suppressing flow rate, future tests to use completion string
- Minor condensate recovered towards the end of testing
- Unstimulated rate achieved was 1.3 MMSCFPD
- Plan to plug, perforate and stimulate 5 stages consecutively
- Economic initial flow rate considered at 2.5 MMSCFPD
- Managing Director Neil Young asserts the project's significant potential
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| African Gold Limited (A1G) ORDINARY FULLY PAID |
Materials |
$65 |
Trading Halt
|
16 Aug 2024 9:14AM |
$0.024 |
$0.135 |
risen by
462.50%
|
|
A1G - Price-sensitive ASX Announcement
Full Release
Key Points
- African Gold Ltd (ASX: A1G) requested a trading halt.
- The trading halt is effective immediately, pending an announcement on capital raising.
- Trading will resume no later than the commencement of trading on Tuesday, 20 August 2024.
- The company does not see any reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$141 |
Release of Securities from Voluntary Escrow
|
16 Aug 2024 9:13AM |
$0.635 |
$1.005 |
risen by
58.27%
|
|
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$109 |
Proposed Issue of Securities to Chief Executive Officer
|
16 Aug 2024 9:12AM |
$0.032 |
$0.067 |
risen by
109.38%
|
|
| Central Petroleum Limited (CTP) ORDINARY FULLY PAID |
Energy |
$42 |
Presentation for FY24 Fourth Quarter Results and Update
|
16 Aug 2024 9:11AM |
$0.050 |
$0.057 |
risen by
14%
|
|
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$109 |
Notification regarding unquoted securities - SNT
|
16 Aug 2024 9:09AM |
$0.032 |
$0.067 |
risen by
109.38%
|
|
| MRG Metals Limited (MRQ) ORDINARY FULLY PAID |
Materials |
$8 |
MRG Accelerates Exploration at Zimbabwe and Mozambique
|
16 Aug 2024 9:09AM |
$0.004 |
$0.003 |
fallen by
14.29%
|
|
| Top Shelf International Holdings Ltd (TSI) ORDINARY FULLY PAID |
Consumer Staple |
$13 |
Resignation of Non-executive Director
|
16 Aug 2024 9:09AM |
$0.090 |
$0.040 |
fallen by
55.56%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$18 |
Launch of Medicinal Cannabis Brand Wellness Life for SAS
|
16 Aug 2024 9:07AM |
$0.023 |
$0.265 |
risen by
1,052.17%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Launch of medicinal cannabis brand Wellness Life.
- Partnership with OneLife Botanicals.
- Products available for prescription by registered medical professionals.
- Products can be ordered by pharmacies through The Entourage Effect.
- Dr. Mihindu Jayasuriya and Dr. Tony Farag appointed as senior medical advisors.
- Training and education provided to pharmacies and practitioners.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$175 |
Update - Notification of buy-back - CEH
|
16 Aug 2024 9:07AM |
$0.500 |
$0.405 |
fallen by
19%
|
|
| Galilee Energy Limited (GLL) ORDINARY FULLY PAID |
Energy |
$5 |
Update - Proposed issue of securities - GLL
|
16 Aug 2024 9:06AM |
$0.017 |
$0.007 |
fallen by
58.82%
|
|
| Linius Technologies Limited (LNU) ORDINARY FULLY PAID |
Information Technology |
$6 |
Request for Extension of Voluntary Suspension
|
16 Aug 2024 9:05AM |
$0.002 |
$0.001 |
fallen by
50%
|
|
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$36 |
SPONTAN Prescribed to First Patient by Authorised Prescriber
|
16 Aug 2024 9:05AM |
$1.375 |
$0.325 |
fallen by
76.36%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- First select group of patients receive SPONTAN under the TGA Authorised Prescriber Scheme (APS).
- APS provides faster and broader patient access to SPONTAN for those with erectile dysfunction.
- Professor Eric Chung leads the milestone prescription under the APS.
- SPONTAN is an innovative, fast-acting, on-demand nasal spray treatment for erectile dysfunction.
- LTR Pharma's strategy involves a Key Opinion Leader (KOL) approach.
- The Authorised Prescriber Scheme allows prescribing unapproved therapeutic goods without needing individual patient approvals.
- LTR Pharma focuses on improving men’s health through an innovative nasal spray treatment for erectile dysfunction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The a2 Milk Company Limited (A2M) ORDINARY FULLY PAID |
Consumer Staple |
$5,951 |
Settlement of various matters in dispute
|
16 Aug 2024 9:05AM |
$6.720 |
$8.220 |
risen by
22.32%
|
|
A2M - Price-sensitive ASX Announcement
Full Release
Key Points
- Resolution of various disputes between a2MC and Synlait, including exclusivity and pricing disputes.
- Synlait accepts the cancellation of exclusive manufacturing and supply rights for a2MC's infant milk formula (IMF) products.
- a2MC owns the intellectual property rights for the Product Specifications of the IMF products.
- Synlait's obligation to procure a minimum annual volume of product continues.
- a2MC to make a one-off payment to Synlait of NZ$24.75 million to resolve pricing and other disputes.
- a2MC’s US IMF products to be supplied under existing terms, with a2MC contributing to certain Synlait development and FDA registration costs.
- Synlait continues to hold Chinese regulatory SAMR registration for certain a2MC products.
- The settlement is conditional on Synlait completing its equity raise and refinancing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$404 |
A2M: Settlement of various matters in dispute
|
16 Aug 2024 9:05AM |
$0.275 |
$0.670 |
risen by
143.64%
|
|
SM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Synlait accepts the validity of a2MC’s notice dated 15 September 2023 cancelling the exclusive manufacturing and supply rights.
- Synlait’s manufacturing and supply exclusivity ceases from 1 January 2025.
- a2MC owns the intellectual property rights for the Product Specifications of the infant milk formula (IMF) products.
- Synlait’s obligation to procure the supply of a minimum annual volume of product will continue.
- The Nutritional Products Manufacturing and Supply Agreement (NPMSA) remains in place but may be terminated by either party on three years' notice.
- a2MC to make a one-off payment to Synlait of NZ$24.75 million to resolve various pricing and other disputes.
- a2MC’s US IMF products are to be supplied under the terms of the NPMSA.
- Synlait continues to hold the Chinese regulatory SAMR registration for a2MC’s Chinese labelled a2 ??® Infant Formula until September 2027.
- Synlait will make available to a2MC an additional slot at Dunsandel for a potential new China Label registered product.
- The settlement is conditional on Synlait completing its equity raise and refinancing its existing banking facilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$404 |
Synlait & The a2 Milk Company settle disputes
|
16 Aug 2024 9:04AM |
$0.275 |
$0.670 |
risen by
143.64%
|
|
SM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Settlement conditional on completion of Synlait’s deleveraging plan.
- Major shareholders indicate support for the settlement.
- The a2 Milk Company will make a one-off settlement payment of approximately $24.75 million to Synlait.
- Exclusivity under the Nutritional Powders Manufacturing and Supply Agreement (NPMSA) will cease from 1 January 2025.
- Synlait will continue to hold the Chinese regulatory State Administration for Market Regulation (SAMR) registration until September 2027.
- Synlait and The a2 Milk Company will collaborate on a potential new China Label registered product.
- Synlait expects minimal impact on overall profitability due to additional costs and adjustments to manufacturing standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Birddog Technology Limited (BDT) ORDINARY FULLY PAID |
Information Technology |
$8 |
Becoming a substantial holder
|
16 Aug 2024 9:04AM |
$0.066 |
$0.047 |
fallen by
28.79%
|
|
| Perseus Mining Limited (PRU) ORDINARY FULLY PAID |
Materials |
$5,120 |
Perseus appoints new Chief Operating Officer
|
16 Aug 2024 9:02AM |
$2.470 |
$3.750 |
risen by
51.82%
|
|
| Galilee Energy Limited (GLL) ORDINARY FULLY PAID |
Energy |
$5 |
Update - Proposed issue of securities - GLL
|
16 Aug 2024 9:02AM |
$0.017 |
$0.007 |
fallen by
58.82%
|
|
| Thunderbird Resources Limited (THB) ORDINARY FULLY PAID |
Materials |
$4 |
General Meeting - Notice and Access Letter
|
16 Aug 2024 9:00AM |
$0.027 |
$0.012 |
fallen by
55.56%
|
|
| ANZ Group Holdings Limited (ANZ) ORDINARY FULLY PAID |
Financials |
$86,378 |
Update - Notification of buy-back - ANZ
|
16 Aug 2024 9:00AM |
$29.190 |
$29.070 |
fallen by
0.41%
|
|
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$129 |
s708A Notice - Issue of Shares
|
16 Aug 2024 8:59AM |
$0.054 |
$0.270 |
risen by
400%
|
|
| Galilee Energy Limited (GLL) ORDINARY FULLY PAID |
Energy |
$5 |
Cleansing Notice
|
16 Aug 2024 8:59AM |
$0.017 |
$0.007 |
fallen by
58.82%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
